経口固形製剤の世界市場レポート 2025年

経口固形製剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.3％で8,421億5,000万米ドルに成長します。予測期間の成長は、個別化医療の需要、放出制御の採用、バイオ医薬品への注力、新興市場の拡大、政策と償還の変更に起因すると考えられます。予測期間における主な動向としては、個別化医療の採用、デジタルヘルス統合、遠隔医療サービスの台頭、予防ヘルスケアへの注力、ヘルスケアにおける人工知能の継続的拡大などが挙げられます。

慢性疾患の蔓延は、経口固形製剤市場の拡大を牽引すると予想されます。慢性疾患とは、長期にわたって持続する健康状態のことで、通常は3カ月以上続きます。人口の高齢化、座りがちなライフスタイル、食生活の乱れ、環境の影響、発見・診断の進歩などの要因が慢性疾患の増加に寄与しています。経口固形製剤は、便利で安定性があり、正確な投与が可能であるため、長期にわたる治療のアドヒアランスをサポートする慢性疾患管理において重要な役割を果たしています。例えば、2024年2月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2050年までに新たに発生するがん患者数が3,500万人を超え、2022年の推定2,000万人から77％増加すると予測しています。このため、慢性疾患の増加が経口固形製剤市場の成長促進要因となっています。

経口固形製剤市場の主なプレーヤーは、ドラッグデリバリーを改善し、バイオアベイラビリティを高め、患者にとってより便利な投与オプションを提供するために、液体充填カプセルなどの革新的な製品の開発に注力しています。液体充填カプセルは、有効医薬品成分（API）と賦形剤を含む液体または半固体製剤を充填したゼラチンシェルからなる経口剤形の一種であり、バイオアベイラビリティと吸収率を向上させた高度な送達システムを提供します。例えば、インドの製薬会社Zeon Lifesciences Ltd.は、2023年7月に液体充填カプセルを発表しました。このカプセルは、最大限の有効性と即効性のために有効成分の最適レベルを確保する革新的な送達システムを特徴としています。このカプセルは正確で一貫した投与量を提供し、患者の服薬コンプライアンスと服薬管理を促進することで、製薬業界における患者ケアとコンプライアンスの新たな基準を打ち立てています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界経口固形製剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の経口固形製剤市場：成長率分析
• 世界の経口固形製剤市場の実績：規模と成長, 2019-2024
• 世界の経口固形製剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界経口固形製剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の経口固形製剤市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• カプセル
• 粉末と顆粒
• ロゼンジとパスティル
• グミ
• 世界の経口固形製剤市場：機構別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 制御放出
• 即時リリース
• 遅延放出
• 世界の経口固形製剤市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• ドラッグストア
• オンライン薬局
• ハイパーマーケットまたはスーパーマーケット
• 世界の経口固形製剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大企業
• 中小企業
• その他のエンドユーザー
• 世界の経口固形製剤市場錠剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 即放錠
• 徐放錠
• 徐放錠
• 発泡錠
• チュアブル錠
• 舌下錠
• 世界の経口固形製剤市場カプセルの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハードゼラチンカプセル
• ソフトジェルカプセル
• 液体入りカプセル
• 遅延放出カプセル
• 世界の経口固形製剤市場粉末および顆粒の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口粉末（再構成）
• 顆粒剤（経口懸濁液または分散性顆粒剤）
• 世界の経口固形製剤市場ロゼンジとパステルの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬用ロゼンジ
• ハーブロゼンジ
• 無糖のロゼンジ
• パスティル（喉や咳の緩和）

第7章 地域別・国別分析

• 世界の経口固形製剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の経口固形製剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経口固形製剤市場：競合情勢
• 経口固形製剤市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• AstraZeneca Plc.
• Novartis AG
• Hoffman-La-Roche Ltd.
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Boehringer Ingelheim GmbH
• Gilead Sciences
• Amgen Inc.
• Teva Pharmaceuticals
• Otsuka Pharmaceutical Co. Ltd.
• Astellas Pharma Inc.
• Biogen Inc.
• Lonza Group
• Catalent Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 経口固形製剤市場2029：新たな機会を提供する国
• 経口固形製剤市場2029：新たな機会を提供するセグメント
• 経口固形製剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oral solid dosage pharmaceutical formulations are medications designed to be taken orally in a solid form. These formulations are intended to be ingested and then dissolved or dispersed in the gastrointestinal tract, allowing the active pharmaceutical ingredients (APIs) to be absorbed into the bloodstream, thereby exerting their therapeutic effects. They represent a fundamental aspect of modern medicine, providing a dependable, convenient, and efficacious means of drug delivery.

The primary dosage forms of oral solid dosage pharmaceutical formulations include tablets, capsules, powders and granules, lozenges and pastilles, and gummies. Tablets are solid oral dosage forms created by compressing powdered active ingredients and excipients into a compact, easily ingestible shape. These formulations may incorporate various release mechanisms such as controlled release, immediate release, and delayed release. They are distributed through various channels including hospital pharmacies, retail pharmacies, drug stores, online pharmacies, and hypermarkets or supermarkets, and are utilized by a diverse range of end-users including large, medium, and small-sized companies, among others.

The oral solid dosage pharmaceutical formulation market research report is one of a series of new reports from The Business Research Company that provides oral solid dosage pharmaceutical formulation market statistics, including oral solid dosage pharmaceutical formulation industry global market size, regional shares, competitors with an oral solid dosage pharmaceutical formulation market share, detailed oral solid dosage pharmaceutical formulation market segments, market trends and opportunities, and any further data you may need to thrive in the oral solid dosage pharmaceutical formulation industry. This oral solid dosage pharmaceutical formulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral solid dosage pharmaceutical formulation market size has grown strongly in recent years. It will grow from $618.34 billion in 2024 to $659.54 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to chronic disease prevalence, aging population, healthcare access expansion, generic formulation promotion, and consumer preference shift.

The oral solid dosage pharmaceutical formulation market size is expected to see strong growth in the next few years. It will grow to $842.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to personalized medicine demand, controlled-release adoption, biopharmaceutical focus, emerging market expansion, and policy and reimbursement changes. Major trends in the forecast period include personalized medicine adoption, digital health integration, the rise of telemedicine services, focus on preventive healthcare, and continued expansion of artificial intelligence in healthcare.

The growing prevalence of chronic diseases is expected to drive the expansion of the oral solid dosage pharmaceutical formulation market. Chronic diseases are long-term health conditions that persist for an extended period, typically lasting three months or more. Factors such as aging populations, sedentary lifestyles, poor dietary habits, environmental influences, and advances in detection and diagnosis are contributing to the rise in chronic diseases. Oral solid dosage formulations play a crucial role in chronic disease management, as they are convenient, stable, and provide precise dosing, which supports long-term treatment adherence. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic diseases is a key driver of growth in the oral solid dosage pharmaceutical formulation market.

Key players in the oral solid dosage pharmaceutical formulation market are focusing on developing innovative products, such as liquid-filled capsules, to improve drug delivery, enhance bioavailability, and provide more convenient dosing options for patients. Liquid-filled capsules, a type of oral dosage form comprising a gelatin shell filled with a liquid or semi-solid formulation containing active pharmaceutical ingredients (APIs) and excipients, offer advanced delivery systems with enhanced bioavailability and absorption rates. For example, Zeon Lifesciences Ltd., an India-based pharmaceutical company, introduced liquid-filled capsules in July 2023, featuring an innovative delivery system that ensures optimal levels of active ingredients for maximum efficacy and immediate results. These capsules provide precise and consistent dosages, promoting patient compliance and control over medication administration, thus setting a new standard for patient care and compliance in the pharmaceutical industry.

In March 2024, Roquette Freres, a France-based food company, acquired IFF Pharma Solutions for $2.85 billion. This strategic acquisition strengthens Roquette's position in the pharmaceutical industry, expands its product range, enhances formulation capabilities, and fortifies its global presence, positioning the company as a key player in innovative drug delivery solutions. IFF Pharma Solutions, a US-based company providing pharmaceutical solutions including tablets and capsules, complements Roquette's objectives, offering synergistic opportunities for growth and innovation.

Major companies operating in the oral solid dosage pharmaceutical formulation market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc., Novartis AG, Hoffman-La-Roche Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim GmbH, Gilead Sciences, Amgen Inc., Teva Pharmaceuticals, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Biogen Inc., Lonza Group, Catalent Inc., Ashland Inc., Piramal Pharma Solutions, Jubilant Pharmova, CordenPharma International.

North America was the largest region in the oral solid dosage pharmaceutical formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral solid dosage pharmaceutical formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral solid dosage pharmaceutical formulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral solid dosage pharmaceutical formulation market consists of sales of chewable tablets, multivitamin tablets, aspirin tablets, probiotic capsules, and protein powders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Solid Dosage Pharmaceutical Formulation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral solid dosage pharmaceutical formulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral solid dosage pharmaceutical formulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral solid dosage pharmaceutical formulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage Form: Tablets; Capsules; Powders And Granules; Lozenges And Pastilles; Gummies
• 2) By Mechanism: Controlled-Release; Immediate-Release; Delayed-Release
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Online Pharmacies; Hypermarkets Or Supermarkets
• 4) By End-User: Large-Size Companies; Medium And Small-Size Companies; Other End-Users
• Subsegments:
• 1) By Tablets: Immediate-Release Tablets; Extended-Release Tablets; Controlled-Release Tablets; Effervescent Tablets; Chewable Tablets; Sublingual Tablets
• 2) By Capsules: Hard Gelatin Capsules; Soft Gel Capsules; Liquid-Filled Capsules; Delayed-Release Capsules
• 3) By Powders And Granules: Oral Powders (Reconstitution); Granules (Oral Suspension Or Dispersible Granules)
• 4) By Lozenges And Pastilles: Medicinal Lozenges; Herbal Lozenges; Sugar-Free Lozenges; Pastilles ( Throat Or Cough Relief)
• 5) By Gummies: Vitamin Gummies; Herbal And Nutritional Supplement Gummies; Pharmaceutical Gummies ( Pain Relief Or Sleep Aids)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oral Solid Dosage Pharmaceutical Formulation Market Characteristics

3. Oral Solid Dosage Pharmaceutical Formulation Market Trends And Strategies

4. Oral Solid Dosage Pharmaceutical Formulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Oral Solid Dosage Pharmaceutical Formulation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oral Solid Dosage Pharmaceutical Formulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oral Solid Dosage Pharmaceutical Formulation Market Growth Rate Analysis
• 5.4. Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oral Solid Dosage Pharmaceutical Formulation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oral Solid Dosage Pharmaceutical Formulation Total Addressable Market (TAM)

6. Oral Solid Dosage Pharmaceutical Formulation Market Segmentation

• 6.1. Global Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Powders And Granules
• Lozenges And Pastilles
• Gummies
• 6.2. Global Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Controlled-Release
• Immediate-Release
• Delayed-Release
• 6.3. Global Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• Hypermarkets Or Supermarkets
• 6.4. Global Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Large-Size Companies
• Medium And Small-Size Companies
• Other End-Users
• 6.5. Global Oral Solid Dosage Pharmaceutical Formulation Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Extended-Release Tablets
• Controlled-Release Tablets
• Effervescent Tablets
• Chewable Tablets
• Sublingual Tablets
• 6.6. Global Oral Solid Dosage Pharmaceutical Formulation Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard Gelatin Capsules
• Soft Gel Capsules
• Liquid-Filled Capsules
• Delayed-Release Capsules
• 6.7. Global Oral Solid Dosage Pharmaceutical Formulation Market, Sub-Segmentation Of Powders And Granules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Powders (Reconstitution)
• Granules (Oral Suspension Or Dispersible Granules)
• 6.8. Global Oral Solid Dosage Pharmaceutical Formulation Market, Sub-Segmentation Of Lozenges And Pastilles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medicinal Lozenges
• Herbal Lozenges
• Sugar-Free Lozenges
• Pastilles (Throat Or Cough Relief)

7. Oral Solid Dosage Pharmaceutical Formulation Market Regional And Country Analysis

• 7.1. Global Oral Solid Dosage Pharmaceutical Formulation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oral Solid Dosage Pharmaceutical Formulation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market

• 8.1. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oral Solid Dosage Pharmaceutical Formulation Market

• 9.1. China Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 9.2. China Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oral Solid Dosage Pharmaceutical Formulation Market

• 10.1. India Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oral Solid Dosage Pharmaceutical Formulation Market

• 11.1. Japan Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 11.2. Japan Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oral Solid Dosage Pharmaceutical Formulation Market

• 12.1. Australia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oral Solid Dosage Pharmaceutical Formulation Market

• 13.1. Indonesia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oral Solid Dosage Pharmaceutical Formulation Market

• 14.1. South Korea Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 14.2. South Korea Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oral Solid Dosage Pharmaceutical Formulation Market

• 15.1. Western Europe Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 15.2. Western Europe Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oral Solid Dosage Pharmaceutical Formulation Market

• 16.1. UK Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oral Solid Dosage Pharmaceutical Formulation Market

• 17.1. Germany Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oral Solid Dosage Pharmaceutical Formulation Market

• 18.1. France Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oral Solid Dosage Pharmaceutical Formulation Market

• 19.1. Italy Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oral Solid Dosage Pharmaceutical Formulation Market

• 20.1. Spain Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oral Solid Dosage Pharmaceutical Formulation Market

• 21.1. Eastern Europe Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 21.2. Eastern Europe Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oral Solid Dosage Pharmaceutical Formulation Market

• 22.1. Russia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oral Solid Dosage Pharmaceutical Formulation Market

• 23.1. North America Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 23.2. North America Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oral Solid Dosage Pharmaceutical Formulation Market

• 24.1. USA Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 24.2. USA Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oral Solid Dosage Pharmaceutical Formulation Market

• 25.1. Canada Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 25.2. Canada Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oral Solid Dosage Pharmaceutical Formulation Market

• 26.1. South America Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 26.2. South America Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oral Solid Dosage Pharmaceutical Formulation Market

• 27.1. Brazil Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oral Solid Dosage Pharmaceutical Formulation Market

• 28.1. Middle East Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 28.2. Middle East Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oral Solid Dosage Pharmaceutical Formulation Market

• 29.1. Africa Oral Solid Dosage Pharmaceutical Formulation Market Overview
• 29.2. Africa Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oral Solid Dosage Pharmaceutical Formulation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oral Solid Dosage Pharmaceutical Formulation Market Competitive Landscape And Company Profiles

• 30.1. Oral Solid Dosage Pharmaceutical Formulation Market Competitive Landscape
• 30.2. Oral Solid Dosage Pharmaceutical Formulation Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Oral Solid Dosage Pharmaceutical Formulation Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca Plc.
• 31.3. Novartis AG
• 31.4. Hoffman-La-Roche Ltd.
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Eli Lilly and Company
• 31.7. Boehringer Ingelheim GmbH
• 31.8. Gilead Sciences
• 31.9. Amgen Inc.
• 31.10. Teva Pharmaceuticals
• 31.11. Otsuka Pharmaceutical Co. Ltd.
• 31.12. Astellas Pharma Inc.
• 31.13. Biogen Inc.
• 31.14. Lonza Group
• 31.15. Catalent Inc.

32. Global Oral Solid Dosage Pharmaceutical Formulation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Solid Dosage Pharmaceutical Formulation Market

34. Recent Developments In The Oral Solid Dosage Pharmaceutical Formulation Market

35. Oral Solid Dosage Pharmaceutical Formulation Market High Potential Countries, Segments and Strategies

• 35.1 Oral Solid Dosage Pharmaceutical Formulation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oral Solid Dosage Pharmaceutical Formulation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oral Solid Dosage Pharmaceutical Formulation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer